Search Tag: ARDS

ICU Management

COVID-19-Induced Respiratory Failure and ARDS

2020 02 Sep

Approximately 5% of patients infected by COVID-19 require ICU admission due to acute respiratory distress syndrome (ARDS). Invasive mechanical ventilation is required in a large majority of these patients. Proper ventilatory management during ARDS reduces the risk of ventilator-induced lung injury and can also play a role in improving patient survival.... Read more

ICU Management

Getinge Receives 510(k) Clearance From US FDA For The Servo-air® Mechanical Ventilator

2020 07 Jul

Getinge has received 510(k) clearance from the US Food & Drug Administration (FDA) for the company’s Servo-air® mechanical ventilator, which is part of the Servo family that supports intensive care ventilation ever since the first model was introduced in 1971. "We are happy to be able to help clinicians in their endeavor to save lives by adding... Read more

ICU Management

What is the Relevance of Cytokine Storm to COVID-19?

2020 05 Jul

COVID-19, in its most severe form, leads to life-threatening pneumonia and acute respiratory distress syndrome (ARDS). In patients with this severity of the coronavirus, mortality rate can approach 40 to 50%.    The mechanism of COVID-19 induced lung injury is still vague, but the term cytokine storm is being used quite frequently in scientific publications... Read more

ICU Management

Pulmonary Pathobiology of COVID-19

2020 27 May

The primary cause of death with COVID-19 is progressive respiratory failure. However, despite the widespread infection rates associated with COVID, very little is known about the pathophysiology of the disease. What clinicians do know is that the pathological features resemble acute respiratory distress syndrome (ARDS) and progressive hypoxia. But... Read more

ICU Management

Managing COVID-19 Respiratory Distress

2020 30 Apr

Acute respiratory stress syndrome is one of the primary ways COVID-19 infection manifests in the patient. COVID-19 injures the vascular endothelium, which can lead to multiorgan failure even in young patients without any comorbidities. A wide variation in mortality rates indicates that the key to improving outcomes of ventilatory support could be in... Read more

ICU Management

AMOMED Pharma Offers Drugs for Severe COVID-19 Cases

2020 23 Apr

AMOMED Pharma develops medicinal products for patients suffering from septic shock at the intensive care units. Septic shock is a life-threatening complication in COVID-19 patients.   Most COVID-19 admissions to the intensive care unit are due to severe lung disorders requiring invasive mechanical ventilation; many with acute respiratory distress... Read more

ICU Management

Is COVID-19 Pneumonia ARDS or Not?

2020 18 Apr

COVID-19 pneumonia meets the ARDS Berlin definition. However, it is a specific disease with peculiar phenotypes. The primary characteristic is the dissociation between the severity of the hypoxaemia and the maintenance of respiratory mechanics. Patients with respiratory compliance that is lower or higher than the median value experience severe hypoxaemia. ... Read more

ICU Management

#CoronavirusOutbreak: Caring for the Critically Ill - Trends, Treatment and Mortality

2020 16 Mar

COVID-19 is associated with severe disease requiring intensive care in approximately 5% of proven infections. As with similar outbreaks in the past, including SARS, MERS, A(H7N9), and H1N1, critical care continues to be an integral component of the global response to Coronavirus. You might also like :  Coronavirus and the Potential Role of ECMO... Read more

ICU Management

Top ICU Stories of 2019

2019 28 Dec

As we move into 2020, here's a quick recap of our most clicked stories in ICU in 2019:  Using Biomarkers for Mortality Prediction in Patients With Sepsis A new study evaluated the prognostic value of six biomarkers at onset of sepsis in adult patients with sepsis or septic shock. Risk Factors for Frailty and Death in the ICU... Read more

ICU Management

Risk Factors for ARDS in Mechanically Ventilated Adults

2019 16 Dec

Acute respiratory distress syndrome (ARDS) is an inflammatory process that could lead to diffuse oedema and hypoxaemic respiratory failure. It is also characterised by increased pulmonary vascular permeability, increased lung weight, and loss of aerated lung. In low and middle-income countries, ARDS mortality ranges from 26 to 58%.  A large majority... Read more